A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study

Yazar
Manns, M. P.
Fehmi, T.
Woebse, M.
Wedemeyer, H.
Hardtke, S.
Wranke, A.
Yurdaydin, C.
Heidrich, B.
Kalliopi, Z.
Yalcin, K.
Akarca, U.
Lammert, F.
Haeussinger, D.
Mueller, T.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/102530
https://doi.org/10.1016/s0168-8278(18)31261-3
Koleksiyonlar